TransCure will be attending the 2nd Annual Advances in Immuno-Oncology USA Congress
Our CEO, Patrick NEF, will be in San Diego. during the 2nd Annual Advances in Immuno-Oncology, October 8th to 9th. Meet him there to talk about fully humanized immune system mouse models for immunity-targeted preclinical assessment.
Click here to pre-arrange a face-to-face :
Who are we?
TransCure bioServices is the European Leader CRO specialized in the Advanced Human Immune System Mouse (hu-mouse) Models. We provides in vivo pharmacology preclinical services for Cancer/Immuno-oncology, HIV, Inflammatory Bowel Diseases, Vaccines/Immunization, Immuno-safety…
Highest needs for the large pharmaceutical and biotechnology companies as well as academic laboratories which can profile new preclinical/clinical drug candidates (small molecules, peptides, biologics, mAb, vaccines) targeting immuno-related diseases for translational potential assessment and better predictive activity in clinical studies.. TransCure bioServices is your one stop shop for in vivo pharmacology preclinical expertise.